Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs Observation in Newly Diagnosed Uterine Leiomyosarcoma
NCT00414076Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2006
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in uterine leiomyosarcoma (uLMS), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2006; status: terminated.
02
Drugs
letrozole
03
Conditions
uterine leiomyosarcoma (uLMS)
Beyond the preview
Go deeper on NCT00414076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414076.